Safety of lopinavir/ritonavir for the treatment of HIV-infection

By Vogel Martin   Rockstroh Jürgen K  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 403-420

Informa Healthcare

Access to resources Recommend Favorite

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

By Kumar Gondi N.   Jayanti Venkata K.   Johnson Marianne K.   Uchic John   Thomas Samuel   Lee Ronald D.   Grabowski Brian A.   Sham Hing L.   Kempf Dale J.   Denissen Jon F.   Marsh Kennan C.   Sun Eugene   Roberts Stanley A.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1622-1630

Springer Publishing Company

Access to resources Recommend Favorite

Lopinavir/Ritonavir: A Review of its Use in the Management of HIV-1 Infection

By Croxtall Jamie D.   Perry Caroline M.  

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1885-1915

Adis International

Access to resources Recommend Favorite

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Long-term lopinavir/ritonavir effective in HIV infection

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite